A Response to the Letter to the Editor: "POSEIDON's Missing Piece: Unanswered Questions on PFS Data in High-Risk Subgroups"

Affiliations

¹ Oncology Department, Centre Hospitalier Universitaire Vaudois, Lausanne University, Lausanne, Switzerland. Electronic address: solange.peters@chuv.ch.
² Division of Medical Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Republic of Korea.
³ Sarah Cannon Research Institute, Tennessee Oncology, PLLC, Nashville, Tennessee.

Solange Peters et al. J Thorac Oncol. 2025 Jun.

. 2025 Jun;20(6):e76-e77.

doi: 10.1016/j.jtho.2025.03.048.

¹ Oncology Department, Centre Hospitalier Universitaire Vaudois, Lausanne University, Lausanne, Switzerland. Electronic address: solange.peters@chuv.ch.
² Division of Medical Oncology, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Republic of Korea.
³ Sarah Cannon Research Institute, Tennessee Oncology, PLLC, Nashville, Tennessee.

No abstract available

Conflict of interest statement

Disclosure Since publication of the article, the authors report no further potential conflicts of interest.